Canada has released its first major update to pediatric obesity guidelines in nearly two decades, and the recommendations represent a dramatic departure from past approaches.
In addition to emphasizing traditional strategies such as healthy eating, physical activity, and behavioural support, the new guidelines now encourage physicians to consider prescribing GLP-1 receptor agonists — such as Ozempic and Wegovy — to children as young as 12. They also support the option of bariatric surgery for teenagers starting at age 13, even before exhausting lifestyle-based interventions.
Pizza should be a Holy food group.
